Annachiara Ferrari

787 total citations
24 papers, 384 citations indexed

About

Annachiara Ferrari is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Annachiara Ferrari has authored 24 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Infectious Diseases and 5 papers in Hepatology. Recurrent topics in Annachiara Ferrari's work include Liver Disease Diagnosis and Treatment (6 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Annachiara Ferrari is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Annachiara Ferrari collaborates with scholars based in Italy, United States and Belgium. Annachiara Ferrari's co-authors include A. Albertí, R. Pistis, Alessandro Vario, Donald A. Goldmann, Jonathan Freeman, Carlos Ávila-Figueroa, Douglas K. Richardson, Giada Sebastiani, James Gray and Gaetano Alfano and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Annachiara Ferrari

22 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annachiara Ferrari Italy 9 166 123 64 59 41 24 384
Ignatius K.P. Cheng Hong Kong 15 149 0.9× 100 0.8× 93 1.5× 32 0.5× 19 0.5× 36 568
Suleiman Al-Mohaya Saudi Arabia 11 123 0.7× 80 0.7× 59 0.9× 68 1.2× 5 0.1× 38 340
Ahmed Mitwalli Saudi Arabia 12 146 0.9× 139 1.1× 50 0.8× 31 0.5× 11 0.3× 33 470
Riad Rahhal United States 11 60 0.4× 43 0.3× 13 0.2× 74 1.3× 72 1.8× 40 442
Nadia Ovchinsky United States 11 228 1.4× 186 1.5× 60 0.9× 23 0.4× 34 0.8× 33 456
Steve Rudich United States 11 104 0.6× 189 1.5× 32 0.5× 122 2.1× 9 0.2× 14 623
Piotr Małkowski Poland 17 338 2.0× 430 3.5× 62 1.0× 85 1.4× 10 0.2× 97 771
B. Erbay Türkiye 11 124 0.7× 27 0.2× 46 0.7× 42 0.7× 45 1.1× 20 401
Olynka Vega‐Vega Mexico 12 58 0.3× 36 0.3× 156 2.4× 21 0.4× 22 0.5× 31 389
Mustafa Nazzal United States 9 66 0.4× 72 0.6× 24 0.4× 47 0.8× 5 0.1× 42 341

Countries citing papers authored by Annachiara Ferrari

Since Specialization
Citations

This map shows the geographic impact of Annachiara Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annachiara Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annachiara Ferrari more than expected).

Fields of papers citing papers by Annachiara Ferrari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annachiara Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annachiara Ferrari. The network helps show where Annachiara Ferrari may publish in the future.

Co-authorship network of co-authors of Annachiara Ferrari

This figure shows the co-authorship network connecting the top 25 collaborators of Annachiara Ferrari. A scholar is included among the top collaborators of Annachiara Ferrari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annachiara Ferrari. Annachiara Ferrari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alfano, Gaetano, Francesco Fontana, Silvia Giovanella, et al.. (2023). Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19. Renal Replacement Therapy. 9(1).
2.
Alfano, Gaetano, Annachiara Ferrari, Francesco Fontana, et al.. (2022). Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19. Infezioni in Medicina. 30(1). 11–21. 5 indexed citations
3.
Alfano, Gaetano, Francesco Fontana, Giulia Ligabue, et al.. (2022). Rethinking Chronic Kidney Disease in the Aging Population. Life. 12(11). 1724–1724. 22 indexed citations
4.
Alfano, Gaetano, Francesco Fontana, Silvia Giovanella, et al.. (2022). Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience. Clinical and Experimental Nephrology. 27(2). 171–178. 4 indexed citations
5.
Alfano, Gaetano, Francesco Fontana, Giacomo Mori, et al.. (2021). Clinical Presentation, Renal Histopathological Findings, and Outcome in Patients with Monoclonal Gammopathy and Kidney Disease. International Journal of Nephrology. 2021. 1–9. 3 indexed citations
6.
Ferrari, Annachiara, Gaetano Alfano, & Giovanni Guaraldi. (2021). Persistent SARS-CoV-2 positivity. Infectious Diseases in Clinical Practice. 29(5). e328–e329. 5 indexed citations
7.
Alfano, Gaetano, Annachiara Ferrari, Riccardo Magistroni, et al.. (2021). The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review. Journal of Nephrology. 34(5). 1387–1403. 23 indexed citations
8.
Alfano, Gaetano, Giovanni Guaraldi, Francesco Fontana, et al.. (2020). The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection. Blood Purification. 50(2). 263–267. 13 indexed citations
9.
Alfano, Gaetano, Annachiara Ferrari, Francesco Fontana, et al.. (2020). Hemolytic Anemia as Presentation of T-Cell Large Granular Lymphocytic Leukemia After Kidney Transplantation: A Case Report. Transplantation Proceedings. 52(5). 1617–1618. 7 indexed citations
10.
Alfano, Gaetano, Francesco Fontana, Annachiara Ferrari, et al.. (2020). Incidence of nephrogenic systemic fibrosis after administration of gadoteric acid in patients on renal replacement treatment. Magnetic Resonance Imaging. 70. 1–4. 15 indexed citations
11.
Alfano, Gaetano, Giacomo Mori, Francesco Fontana, et al.. (2018). Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study. International Journal of STD & AIDS. 29(13). 1305–1315. 16 indexed citations
12.
13.
Sebastiani, Giada, Alessandro Vario, Annachiara Ferrari, et al.. (2005). Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C. Journal of Viral Hepatitis. 13(3). 199–205. 47 indexed citations
14.
Albertí, A., Alessandro Vario, Annachiara Ferrari, & R. Pistis. (2005). Review article: chronic hepatitis C – natural history and cofactors. Alimentary Pharmacology & Therapeutics. 22(s2). 74–78. 62 indexed citations
15.
Sebastiani, Giada, Alessandro Vario, Annachiara Ferrari, et al.. (2005). Combination of non invasive markers to identify liver fibrosis in HCV patients with persistently normal ALT (PNALT). 42. 1 indexed citations
16.
Albertí, A., et al.. (2004). Natural history of initially mild chronic hepatitis C. Digestive and Liver Disease. 36(10). 646–654. 40 indexed citations
17.
Ávila-Figueroa, Carlos, Donald A. Goldmann, Douglas K. Richardson, et al.. (1998). Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. The Pediatric Infectious Disease Journal. 17(1). 10–17. 93 indexed citations
18.
Ferrari, Annachiara, D Van Linthoudt, Luigi Antonio Morrone, et al.. (1996). NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND PROSTAGLANDINS. American Journal of Therapeutics. 3(3). 189–194. 7 indexed citations
19.
Trande, P., Pasquale Esposito, Santino Marchi, et al.. (1996). Hepatitis C Virus-positive (HCV) Chronic Active Hepatitis (CAH): a randomized controlled trial of IFN ? Colchicine.. 2 indexed citations
20.
Gray, Alan L., et al.. (1965). AUTOMATED HEMAGGLUTINATION ASSAYS. Annals of the New York Academy of Sciences. 130(2). 809–818. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ignatius K.P. Cheng Breakdown of academic impact, for papers by Suleiman Al-Mohaya Breakdown of academic impact, for papers by Ahmed Mitwalli Breakdown of academic impact, for papers by Riad Rahhal Breakdown of academic impact, for papers by Nadia Ovchinsky Breakdown of academic impact, for papers by Steve Rudich Breakdown of academic impact, for papers by Piotr Małkowski Breakdown of academic impact, for papers by B. Erbay Breakdown of academic impact, for papers by Olynka Vega‐Vega Breakdown of academic impact, for papers by Mustafa Nazzal
Rankless by CCL
2026